1. Describe the latest treatments of breast cancer.
2. Identify the latest information on clinical relevance of biomarkers for breast cancer.
3. Describe recent changes with regards to HER2-directed therapy in breast cancer
4. Contextualize these HER2-directed therapy updates within current practice
5. Explain the use of immunotherapy in triple negative breast cancer
Session date:
01/15/2020 - 8:00am to 9:00am CST
Location:
Room G5/119 CSC
600 Highland Avenue
Madison, WI
53792
United States
See map: Google Maps
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Mark Burkard, MD
Amye J Tevaarwerk, MD
Ruth O'Regan, MD